- Home
- MYGN vs LION Comparison
MYGN vs LION Comparison
Compare MYGN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- LION
- Stock Information
- Founded
- MYGN 1991
- LION 1997
- Country
- MYGN United States
- LION United States
- Employees
- MYGN N/A
- LION N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LION Movies/Entertainment
- Sector
- MYGN Health Care
- LION Consumer Discretionary
- Exchange
- MYGN Nasdaq
- LION Nasdaq
- Market Cap
- MYGN 642.0M
- LION 1.9B
- IPO Year
- MYGN 1995
- LION N/A
- Fundamental
- Price
- MYGN $7.40
- LION $7.17
- Analyst Decision
- MYGN Hold
- LION Buy
- Analyst Count
- MYGN 13
- LION 9
- Target Price
- MYGN $13.50
- LION $8.88
- AVG Volume (30 Days)
- MYGN 1.3M
- LION 2.6M
- Earning Date
- MYGN 11-06-2025
- LION 11-06-2025
- Dividend Yield
- MYGN N/A
- LION N/A
- EPS Growth
- MYGN N/A
- LION N/A
- EPS
- MYGN N/A
- LION N/A
- Revenue
- MYGN $832,900,000.00
- LION $3,986,900,000.00
- Revenue This Year
- MYGN $0.17
- LION N/A
- Revenue Next Year
- MYGN $6.19
- LION $16.90
- P/E Ratio
- MYGN N/A
- LION N/A
- Revenue Growth
- MYGN 3.83
- LION 10.89
- 52 Week Low
- MYGN $3.76
- LION $5.55
- 52 Week High
- MYGN $29.30
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- MYGN 66.01
- LION 60.87
- Support Level
- MYGN $7.13
- LION $7.06
- Resistance Level
- MYGN $7.80
- LION $7.69
- Average True Range (ATR)
- MYGN 0.44
- LION 0.31
- MACD
- MYGN 0.04
- LION 0.09
- Stochastic Oscillator
- MYGN 78.61
- LION 66.98
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.